A Randomized, Single-Blinded, Phase 3 Study of Second- or Third-Line Chemotherapy with Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients with Advanced Non-Small Cell Lung Cancer with at Least One Measurable Lung Lesion (BPI 2358 103)

June 22, 2018
https://clinicaltrials.gov/ct2/show/NCT02504489
Cancer - Lung
Principal Investigator: Igor I Rybkin, MD
Lung cancer, lung, cancer, BPI 103,
Accepting Participants